Pricing Log in Create free account
Friday 6 November 2026 Export HCM’s income statement to Excel — free account

HUTCHMED (China) Limited Sponsored ADR

HCM Healthcare Drug Manufacturers Specialty & Generic

HUTCHMED (China) Limited Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $548.5 million, down 13.0% from fiscal 2024.

14.27 0.35 +2.51%
Market cap
$2.5B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
4/9
Altman Z
3.53
Beneish M
−1.20
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

HUTCHMED (China) Limited Sponsored ADR (HCM) Debt to equity

Alert me on Debt to equity

HUTCHMED (China) Limited Sponsored ADR's debt to equity at the end of the quarter to 30 June 2026 was 0.1×, down 0.0× from fiscal 2025 (0.1×). Over the past ten years it has ranged from 0.1× (fiscal 2018) to 0.5× (fiscal 2015); the current reading is higher than 18% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 0.0× and above the Healthcare sector median of 0.0×.

Debt to equity, annual

Embed this chart

Annual newest first

Period Debt to equity Change
FY2025 0.1× (30.57%)
FY2024 0.1× 0.56%
FY2023 0.1× 28.09%
FY2022 0.1× (78.92%)
FY2021 0.4× 235.48%
FY2020 0.1× (42.08%)
FY2019 0.2× 174.12%
FY2018 0.1× (2.11%)
FY2017 0.1× (66.94%)
FY2016 0.2× (52.95%)

Quarterly newest first

Period Debt to equity Change
Jun 2026 0.1× (0.54%)
Dec 2025 0.1× (0.93%)
Jun 2025 0.1× (29.92%)
Dec 2024 0.1× (1.74%)
20 more quarters

Against its own ten years

Low 0.1× High 0.5×
Ten-year median 0.1×
Current reading's percentile 18

Debt to equity against peers

Company Debt to equity
ALVO Alvotech compare −6.8×
PBH Prestige Consumer Healthcare Inc. compare 0.0×
BCRX BioCryst Pharmaceuticals, Inc. compare 0.0×
RGC Regencell Bioscience Holdings Limited compare 0.0×
TRLV Trulieve Cannabis Corp. compare 0.0×
ANIP ANI Pharmaceuticals, Inc. compare 0.0×
HCM HUTCHMED (China) Limited Sponsored ADR 0.1×
PRGO Perrigo Company plc compare 1.3×
XERS Xeris Biopharma Holdings, Inc. compare 3.9×
Drug Manufacturers Specialty & Generic industry median 0.0×
Healthcare sector median 0.0×
Market median 0.1×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on HCM